Short Interest Update on Charles River Laboratories International (CRL)

Charles River Laboratories International (CRL) has 1,708,317 shares of shorts outstanding as on August 15, 2016, with 4 days left to cover or roll them over. On Jul 29, 2016, the open interest of short positions was 1,762,571 shares. The stock has a decent trading volume of 406,102 shares daily. The marginal decrease in the short positions is by -3.1%, which amounts to -54,254 shares. Short positions are 3.7% of the available float. The short interest information was released on Wednesday Aug 24th after the market close.

Charles River Laboratories International (NYSE:CRL): The stock opened at $83.61 on Wednesday but the bulls could not build on the opening and the stock topped out at $84.56 for the day. The stock traded down to $81.76 during the day, due to lack of any buying support eventually closed down at $81.92 with a loss of -1.95% for the day. The stock had closed at $83.55 on the previous day. The total traded volume was 364,471 shares.


In a related news, The Securities and Exchange Commission has divulged that Foster James C, director officer (Chairman, President and CEO) of Charles River Laboratories International Inc, had unloaded 3,830 shares at an average price of $86.92 in a transaction dated on August 5, 2016. The total value of the transaction was worth $332,904.

Charles River Laboratories International, Inc. is a full service, early stage contract research company. The Company offers research models for the research and development of new drugs, devices and therapies. It develops a portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP that support the clients from target identification through preclinical development. The Company operates through three segments: Research Models and Services (RMS), which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides services that enables the clients to outsource their drug discovery research, critical, regulatory-required safety assessment testing and related drug discovery and development activities, and Manufacturing Support (Manufacturing), which is involved in the production and release of products manufactured by the clients.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *